Department of Defense
The $40 million Department of Defense research program into restoring memory will use NeuroPace's implantable neurostimulator, a move that the company said could help it expand the product's indications beyond epilepsy.
Soon, there will be a device to cure some forgetfulness if the Department of Defense's four-year grant of up to $40 million succeeds in fostering implants and electronic interfaces that diagnose and treat memory loss due to traumatic brain injury.
Implantable drug delivery startup Pharmaco-Kinesis has persuaded the U.S. Department of Defense to fund another potential use for its technology.
The Department of Defense has selected Denmark's Bavarian Nordic to develop a vaccine against two potential biological pathogens deemed to be threats to national security.
Terumo BCT, the blood-focused division of the Japanese med tech giant, has signed a deal with the U.S. Department of Defense to share costs in the development of a device that can treat donated blood used in emergency transfusions.
Founded just 5 years ago, Combat Medical Systems nailed down an $86 million U.S. Department of Defense contract to provide a slew of medical equipment and devices for military and federal agencies over the next 5 years.
Sarepta Therapeutics is getting closer to developing a therapy to treat a rare animal-borne disease considered a bioterrorism threat by the Centers for Disease Control and Prevention.
The big defense contractor General Dynamics is hiring a team to help it execute on a $41.8 million contract to develop new drugs, devices and vaccines for the military.
A unit of the U.S. Department of Defense has challenged the Foldit video gamers to craft proteins in a virtual online setting that bind to pathogens in the blood, to bolster research of sepsis treatments.
Luminex has signed an $11.5 million deal with the Department of Defense, tasked with developing a hand-held diagnostics tool that can detect biothreat agents.